A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma | MicrobiomeTrials← Back to trialsNCT04187404
A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
TERMINATEDPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2020-07-23Est. Completion: 2024-10-02
Enrollment target: 70 participants Locations- MD Anderson Cancer Center, Houston, Texas, United States
- Rigshospitalet, Copenhagen, Denmark
- Chu Lille, Lille, France
- Centre Léon Bérard, Lyon, France
- Assistance Publique - Hôpitaux de Marseille - Hôpital Nord, Marseille, France
- Institut Gustave Roussy, Villejuif, France
- Lmu Klinikum, München, Germany
- Universitätsklinikum Würzburg, Würzburg, Germany
- Azienda Ospedaliera Spedali Civili, Brescia, Italy
- Amsterdam UMC, location VUmc, Amsterdam, Netherlands
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Karolinska University Hospital, Stockholm, Sweden
Other microbiome trials you might be interested in
Adrenocortical Carcinoma (ACC)Recurrent Adrenocortical Carcinoma (ACC)Recurrent Abdominal Adrenocortical Carcinoma (ACC)Carcinoma, AdrenocorticalCarcinoma, Adrenal Cortical
Background:
Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal glands. ACC often returns after tumors are r…
Bethesda, United StatesEst. completion Dec 1, 2030
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)
Intrahepatic Bile Duct Cancer
Colorectal Neoplasms
Colorectal Cancer
Cholangiocarcinoma
Bile Duct Neoplasms
Bile Duct Cancer
Adrenocortical Carcinoma (ACC)
Adrenal Cortical Carcinoma
Adrenal Gland Cancer
Adrenal Gland Neoplasms
Adrenal Cortex Neoplasms
Background:
One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body…
Bethesda, United StatesEst. completion Dec 31, 2027
Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid TumorRefractory Solid TumorsSolid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028